Press Releases in 2018

Check out the latest press releases from Novus. For direct media requests, contact us at
View Press Releases From: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

Bio-Techne Supports International Antibody Validation Meetings

Release Date: 
Wednesday, September 19, 2018 - 12:00

MINNEAPOLIS, Sept. 19, 2018 /PRNewswire/ -- Bio-Techne is proud to be sharing its 30+ years of industry leading expertise in antibody development and validation from its R&D Systems and Novus Biologicals brands at the 3rd International Antibody Validation Meeting on September 20-21, 2018.

Bio-Techne Fills a Need for Simple Tools to Study Glycobiology

Release Date: 
Thursday, September 6, 2018 - 12:00

MINNEAPOLIS, Sept. 6, 2018 /PRNewswire/ -- Bio-Techne researchers publish papers that promise to open the field of glycobiology to the masses.

Bio-Techne Introduces GMP Small Molecules for Stem Cell Therapy Development

Release Date: 
Wednesday, August 8, 2018 - 12:00

MINNEAPOLIS, Aug. 8, 2018 /PRNewswire/ -- Bio-Techne has introduced a new range of Tocris Bioscience-branded stem cell research compounds produced to cGMP standards, which are suitable for use as ancillary materials in the development of stem cell therapies.

Bio-Techne Introduces New Member of the Simple Western™ Family, with IR/NIR Detection Capabilities

Release Date: 
Tuesday, July 24, 2018 - 00:00

MINNEAPOLIS, July 24, 2018 /PRNewswire/ -- Bio-Techne again disrupts protein analysis technology with the introduction of the newest member of their ProteinSimple-branded Simple Western family, Jess. This evolutionary technology simplifies protein expression analysis, while speeding up time to result. Jess automates both the protein separation and immunodetection elements characteristic of traditional protein analysis techniques, eliminating many of the tedious, error-prone steps.

Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets

Release Date: 
Tuesday, July 10, 2018 - 00:00

Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results

MINNEAPOLIS, July 10, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of antibody-based reagents for life science and clinical research, has been validating an extensive and growing number of antibodies using recent advances in gene editing technology.

Bio-Techne Leads the Way in Scientific Support for Autophagy Research

Release Date: 
Thursday, April 26, 2018 - 00:00

MINNEAPOLIS, April 26, 2018 /PRNewswire/ -- Bio-Techne, a family of brands providing a unique portfolio of products and services for basic and clinical research, has a leading role supporting autophagy research.

Autophagy (or "self-eating") is an important basic cellular process by which cell components are degraded by lysosomes or vacuoles and recycled. Autophagy plays a crucial role in human health and disease. Disrupted autophagy has been implicated in Parkinson's disease, type 2 diabetes, cancer, and is now a major target for drug discovery and development.

Bio-Techne Expands RNAscope® ISH Automation - Facilitating Drug Discovery and Development

Release Date: 
Wednesday, March 21, 2018 - 00:00

New and updated assays increase application areas and improve performance